Xinlai Cheng

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 15

Top Topics

Oxidative Stress

Structure Activity Relationship

Top Venues

Scientific reports

Pharmaceuticals (Basel, Switzerland)

The Journal of cell biology

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel Schaefer, Xinlai Cheng
Recent Advances in Covalent Drug Discovery. Pharmaceuticals (Basel, Switzerland) 16 (5) (2023)
Sebastian Hasselbeck, Xinlai Cheng
Molecular Marvels: Small Molecules Paving the Way for Enhanced Gene Therapy. Pharmaceuticals (Basel, Switzerland) 17 (1) (2023)
Sebastian Hasselbeck, Xinlai Cheng
Molecular Marvels: Small Molecules Paving the Way for Enhanced Gene Therapy. Pharmaceuticals (Basel, Switzerland) 17 (1) (2023)
Sebastian Hasselbeck, Xinlai Cheng
Molecular Marvels: Small Molecules Paving the Way for Enhanced Gene Therapy. Pharmaceuticals (Basel, Switzerland) 17 (1) (2023)
Rodrigo A Gama-Brambila, Jie Chen, Yasamin Dabiri, Georg Tascher, Václav Němec, Christian Münch, Guangqi Song, Stefan Knapp, Xinlai Cheng
A Chemical Toolbox for Labeling and Degrading Engineered Cas Proteins. JACS Au 1 (6) (2021)
Jun Zhou, Yasamin Dabiri, Rodrigo A Gama-Brambila, Shahrouz Ghafoory, Mukaddes Altinbay, Arianeb Mehrabi, Mohammad Golriz, Biljana Blagojevic, Stefanie Reuter, Kang Han, Anna Seidel, Ivan Đikić, Stefan Wölfl, Xinlai Cheng
pVHL-mediated SMAD3 degradation suppresses TGF-β signaling. The Journal of cell biology 221 (1) (2021)
Xinlai Cheng, Stefanie Haeberle, Iart Luca Shytaj, Rodrigo A Gama-Brambila, Jannick Theobald, Shahrouz Ghafoory, Jessica Wölker, Uttara Basu, Claudia Schmidt, Annika Timm, Katerina Taškova, Andrea S Bauer, Jörg Hoheisel, Nikolaos Tsopoulidis, Oliver T Fackler, Andrea Savarino, Miguel A Andrade-Navarro, Ingo Ott, Marina Lusic, Eva N Hadaschik, Stefan Wölfl
NHC-gold compounds mediate immune suppression through induction of AHR-TGFβ1 signalling in vitro and in scurfy mice. Communications biology 3 (2020)
Jannick Theobald, Mohamed A Abu El Maaty, Nico Kusterer, Bernhard Wetterauer, Michael Wink, Xinlai Cheng, Stefan Wölfl
In vitro metabolic activation of vitamin D3 by using a multi-compartment microfluidic liver-kidney organ on chip platform. Scientific reports 9 (1) (2019)
Yasamin Dabiri, Alice Schmid, Jannick Theobald, Biljana Blagojevic, Wojciech Streciwilk, Ingo Ott, Stefan Wölfl, Xinlai Cheng
A Ruthenium(II) N-Heterocyclic Carbene (NHC) Complex with Naphthalimide Ligand Triggers Apoptosis in Colorectal Cancer Cells via Activating the ROS-p38 MAPK Pathway. International journal of molecular sciences 19 (12) (2018)
Xinlai Cheng, Christiane Peuckert, Stefan Wölfl
Author Correction: Essential role of mitochondrial Stat3 in p38MAPK mediated apoptosis under oxidative stress. Scientific reports 8 (1) (2018)
Xinlai Cheng, Karl-Heinz Merz, Sandra Vatter, Jochen Zeller, Stephan Muehlbeyer, Andrea Thommet, Jochen Christ, Stefan Wölfl, Gerhard Eisenbrand
Identification of a Water-Soluble Indirubin Derivative as Potent Inhibitor of Insulin-like Growth Factor 1 Receptor through Structural Modification of the Parent Natural Molecule. Journal of medicinal chemistry 60 (12) (2017)
Yasamin Dabiri, Sara Kalman, Clara-Marie Gürth, Jee Young Kim, Viola Mayer, Xinlai Cheng
The essential role of TAp73 in bortezomib-induced apoptosis in p53-deficient colorectal cancer cells. Scientific reports 7 (1) (2017)
Xinlai Cheng, Christiane Peuckert, Stefan Wölfl
Essential role of mitochondrial Stat3 in p38MAPK mediated apoptosis under oxidative stress. Scientific reports 7 (1) (2017)
Jannick Theobald, Ali Ghanem, Patrick Wallisch, Amin A Banaeiyan, Miguel A Andrade-Navarro, Katerina Taškova, Manuela Haltmeier, Andreas Kurtz, Holger Becker, Stefanie Reuter, Ralf Mrowka, Xinlai Cheng, Stefan Wölfl
Liver-Kidney-on-Chip To Study Toxicity of Drug Metabolites. ACS biomaterials science & engineering 4 (1) (2017)
Jana Tegethoff, Roland Bischoff, Sawsan Saleh, Biljana Blagojevic, Karl-Heinz Merz, Xinlai Cheng
Methylisoindigo and Its Bromo-Derivatives Are Selective Tyrosine Kinase Inhibitors, Repressing Cellular Stat3 Activity, and Target CD133+ Cancer Stem Cells in PDAC. Molecules (Basel, Switzerland) 22 (9) (2017)